Should Thiotepa-Based Regimens Be the New Transplant Conditioning Strategy for Primary Central Nervous System Lymphoma?
JAMA Oncol
; 7(7): 1003-1004, 2021 07 01.
Article
in En
| MEDLINE
| ID: mdl-33956089
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiotepa
/
Lymphoma
Limits:
Humans
Language:
En
Journal:
JAMA Oncol
Year:
2021
Document type:
Article